正海生物
(300653)
| 流通市值：37.04亿 | | | 总市值：37.04亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 97,415,845.21 | 363,225,351.49 | 291,348,252.99 | 198,024,061.1 |
| 营业收入 | 97,415,845.21 | 363,225,351.49 | 291,348,252.99 | 198,024,061.1 |
| 二、营业总成本 | 69,470,342.54 | 235,693,995.77 | 167,592,844.19 | 111,554,445.87 |
| 营业成本 | 18,548,598.03 | 44,885,424.69 | 36,098,323.13 | 26,287,691.51 |
| 税金及附加 | 694,274.73 | 3,904,992.51 | 2,902,325.89 | 1,932,176.74 |
| 销售费用 | 32,679,942.53 | 119,595,876.65 | 79,889,700.9 | 51,253,724.78 |
| 管理费用 | 7,091,470.94 | 28,301,948.49 | 20,533,766.07 | 12,887,691.29 |
| 研发费用 | 10,539,502.19 | 39,521,831.02 | 28,486,630.76 | 19,552,883.93 |
| 财务费用 | -83,445.88 | -516,077.59 | -317,902.56 | -359,722.38 |
| 其中:利息费用 | 2,765.89 | 13,473.32 | 10,664.72 | 6,227.92 |
| 其中:利息收入 | 129,868.27 | 752,926.5 | 592,429.62 | 496,321.11 |
| 加:公允价值变动收益 | 3,259,154.76 | 5,429,367.62 | 4,260,258.41 | 5,199,696.99 |
| 加:投资收益 | -413,548.52 | 12,623,453.5 | 8,596,038.78 | 4,148,854.71 |
| 信用减值损失(新) | -106,593.67 | -371,609.05 | -249,191.14 | -220,471.45 |
| 其他收益 | 529,530.69 | 7,294,561.52 | 6,923,575 | 2,975,840.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 31,214,045.93 | 152,507,129.31 | 143,286,089.85 | 98,573,535.73 |
| 加:营业外收入 | 29,840.47 | 48,778.57 | 148,981.28 | 2,735.18 |
| 减:营业外支出 | 5,000.33 | 178,131.62 | 66,396.02 | 5,519.26 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 31,238,886.07 | 152,377,776.26 | 143,368,675.11 | 98,570,751.65 |
| 减:所得税费用 | 4,612,162.88 | 17,738,667.26 | 18,312,977.03 | 12,538,645.24 |
| 六、净利润 | 26,626,723.19 | 134,639,109 | 125,055,698.08 | 86,032,106.41 |
| 持续经营净利润 | 26,626,723.19 | 134,639,109 | 125,055,698.08 | 86,032,106.41 |
| 归属于母公司股东的净利润 | 26,626,723.19 | 134,639,109 | 125,055,698.08 | 86,032,106.41 |
| (一)基本每股收益 | 0.15 | 0.75 | 0.69 | 0.48 |
| (二)稀释每股收益 | 0.15 | 0.75 | 0.69 | 0.48 |
| 九、综合收益总额 | 26,626,723.19 | 134,639,109 | 125,055,698.08 | 86,032,106.41 |
| 归属于母公司股东的综合收益总额 | 26,626,723.19 | 134,639,109 | 125,055,698.08 | 86,032,106.41 |
| 公告日期 | 2025-04-22 | 2025-04-15 | 2024-10-23 | 2024-08-06 |
| 审计意见(境内) | | 标准无保留意见 | | |